Trinity Biotech (TRIB) Gains from Investment Securities (2021 - 2024)
Historic Gains from Investment Securities for Trinity Biotech (TRIB) over the last 4 years, with Q4 2024 value amounting to -$233000.0.
- Trinity Biotech's Gains from Investment Securities fell 25846.15% to -$233000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $93000.0, marking a year-over-year decrease of 7129.63%. This contributed to the annual value of $1.0 million for FY2024, which is 22371.79% up from last year.
- Trinity Biotech's Gains from Investment Securities amounted to -$233000.0 in Q4 2024, which was down 25846.15% from -$65000.0 recorded in Q4 2023.
- In the past 5 years, Trinity Biotech's Gains from Investment Securities ranged from a high of $403000.0 in Q3 2023 and a low of -$233000.0 during Q4 2024
- In the last 4 years, Trinity Biotech's Gains from Investment Securities had a median value of -$1036.0 in 2021 and averaged $60742.6.
- Over the last 5 years, Trinity Biotech's Gains from Investment Securities had its largest YoY gain of 2025000.0% in 2023, and its largest YoY loss of 44166.67% in 2023.
- Trinity Biotech's Gains from Investment Securities (Quarter) stood at $395000.0 in 2021, then tumbled by 103.04% to -$12000.0 in 2022, then tumbled by 441.67% to -$65000.0 in 2023, then plummeted by 258.46% to -$233000.0 in 2024.
- Its Gains from Investment Securities was -$233000.0 in Q4 2024, compared to -$65000.0 in Q4 2023 and $403000.0 in Q3 2023.